Trillium Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics

TRIL 20.39

+1.0%

Nov 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (102)	11/12/2017 1:01:12 PM
From: semi_infinite	of 294

Poster gives me more clarity on cytokine response than the abstract that only gave week1 and week6 peaks. Poster added baseline and week6 pre-infusion. Still would need some clarity on how they maintained quality control on measurements across different labs given sample preservation and incubation effects shown in Norway work. Also would like them to present data after complete response in comparison to blood from healthy controls.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next